XBIOTECH INC. Deferred Income, Current
XBIOTECH INC. (XBIT) had Deferred Income, Current of $1.50 million as of 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredIncomeCurrent · last filed 2020-08-10
- 2020-06-30: Deferred Income, Current $1.50M.
- 2020-03-31: Deferred Income, Current $1.50M.
- 2019-12-31: Deferred Income, Current $0.00.
| Period end | Deferred Income, Current |
|---|---|
| 2020-06-30 | $1.50M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.50M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $0.00 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |